Axillary lymph node dissection for malignant melanoma

被引:7
|
作者
Davis, Paul G. [1 ]
Serpell, Jonathan W. [1 ]
Kelly, John W. [2 ]
Paul, Eldho [3 ]
机构
[1] Alfred Hosp, Dept Gen Surg, Prahran, Vic 3181, Australia
[2] Monash Univ, Sch Publ Hlth & Preventat Med, Alfred Hosp, Victorian Melanoma Serv, Clayton, Vic 3800, Australia
[3] Monash Univ, Sch Publ Hlth & Preventat Med, Alfred Hosp, Dept Epidemiol & Preventat Med, Clayton, Vic 3800, Australia
关键词
axilla; malignant melanoma; local recurrence; lymph node dissection; postoperative complications; RISK-FACTORS; CUTANEOUS MELANOMA; LYMPHADENECTOMY; RECURRENCE; MORBIDITY; METASTASIS; PATTERNS; BIOPSY;
D O I
10.1111/j.1445-2197.2010.05491.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Malignant melanoma is a common and life-threatening malignancy that often metastasizes to lymph nodes, necessitating lymph node dissections. Dissections aim for regional disease control. Dissections often result in significant morbidity and are associated with local recurrences (LRs) in the surgical field. This study aims to ascertain the LR rate and complication rate in axillary lymph node dissections (ALND) for malignant melanoma. It also aims to identify risk factors for both LR and complications. Methods: This retrospective clinical study involved the analysis of 74 patients who were identified by the Victorian Melanoma Service database as having ALND between 1999 and 2008. Three patients underwent bilateral ALND and three patients underwent reoperative procedures following initial incomplete dissections. Patient demographics and information on the primary tumour was collected using a prospectively kept database and histopathological reports. Operative and post-operative information was obtained through a retrospective review of clinical notes and histopathological reports. Results: Twelve (16%) patients developed LR at a median follow-up time of 9.5 months, and 32 (46%) patients had a post-operative complication. Kaplan-Meier estimates revealed an overall risk of LR to be 24.96% (95% CI: 13.8%-45.1%). Cox regression analysis revealed that having a primary melanoma upon the abdomen statistically significantly increased the risk of LR in the dissected field. (Hazard ratio 3.84; 95% CI: 1.0-15.0; P = 0.048). Twenty-eight (38%) patients died from disseminated disease. Conclusions: ALND is associated with a significant risk of post-operative complications. It can achieve regional disease control, but a significant risk of LR exists. If LR occurs the prognosis is very poor.
引用
收藏
页码:462 / 466
页数:5
相关论文
共 50 条
  • [1] AXILLARY LYMPH-NODE DISSECTION IN MALIGNANT-MELANOMA
    HOHENBERGER, P
    [J]. LANGENBECKS ARCHIV FUR CHIRURGIE, 1993, 378 (01): : 1 - 3
  • [2] AXILLARY LYMPH-NODE DISSECTION FOR MELANOMA
    HARRIS, MN
    GUMPORT, SL
    MAIWANDI, H
    [J]. SURGERY GYNECOLOGY AND OBSTETRICS WITH INTERNATIONAL ABSTRACTS OF SURGERY, 1972, 135 (06): : 936 - &
  • [3] AXILLARY RECURRENCE FOLLOWING LYMPH-NODE DISSECTION IN MALIGNANT-MELANOMA
    KRETSCHMER, L
    LAUTENSCHLAGER, C
    PREUSSER, KP
    FIEDLER, H
    HETSCHKO, I
    [J]. LANGENBECKS ARCHIV FUR CHIRURGIE, 1993, 378 (01): : 4 - 11
  • [4] Lymph node dissection in malignant melanoma
    Hohenberger, W
    Gohl, J
    AltendorfHofmann, A
    Meyer, T
    [J]. CHIRURG, 1996, 67 (08): : 779 - 787
  • [5] AXILLARY NODE DISSECTION IN MALIGNANT-MELANOMA
    KARAKOUSIS, CP
    GOUMAS, W
    RAO, U
    DRISCOLL, DL
    [J]. AMERICAN JOURNAL OF SURGERY, 1991, 162 (03): : 202 - 207
  • [6] AXILLARY NODE DISSECTION IN MALIGNANT-MELANOMA
    KARAKOUSIS, CP
    RAO, U
    [J]. SURGERY GYNECOLOGY & OBSTETRICS, 1981, 152 (04): : 507 - 510
  • [7] Utility of Level III Axillary Lymph Node Dissection in Melanoma Patients with Palpable Axillary Lymph Node Disease
    Mahvi, David A.
    Fairweather, Mark
    Yoon, Charles H.
    Cho, Nancy L.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 227 (04) : S250 - S250
  • [8] Lymph Node Dissection in Sentinel Lymph Node-positive malignant Melanoma
    Welsch, K.
    Yazdi, A. S.
    [J]. HAUTARZT, 2016, 67 (10): : 848 - 849
  • [9] Lymph node dissection for clinically evident lymph node metastases of malignant melanoma
    Meyer, T
    Merkel, S
    Göhl, J
    Hohenberger, W
    [J]. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2002, 28 (04): : 424 - 430
  • [10] LYMPH-NODE DISSECTION IN MALIGNANT-MELANOMA
    KARAKOUSIS, CP
    STAHL, L
    MOORE, R
    HOLYOKE, ED
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 1980, 13 (03) : 245 - 252